Evercore ISI’s $235 target on ABBV

ABBV AbbVie

$214 → $235 (+10%) by May 2027

Outperform · lowers · said May 19, 2026 · 12-month default horizon

Open: judged on the close on May 19, 2027

The article this target came from

AbbVie (ABBV) Price Target Lowered to $235 at Evercore ISI

Yahoo Finance · May 19, 2026

AbbVie (ABBV) Price Target Lowered to $235 at Evercore ISI

Evercore ISI’s track record → AbbVie →

A fact about what Evercore ISI published, as reported by Yahoo Finance, not a recommendation from Dalsna Finance; Evercore ISI is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.